UCLA HF Guideline
ELITE II showed a low dose of the ARB losartan was not superior or equivalent to ACE inhibitor treatment. CHARM demonstrated benefits of ARB in ACE intolerant patients as well as in patients on ACE inhibitors. Recommend use in patients that cannot tolerate or have unacceptable side effects with ACE inhibitors or as add on therapy to ACE ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.